Clinical Guidelines
Clinical Guidelines
-
AHCDO; 2023
-
AHCDO; 2023
The Australian Haemophilia Centre Directors' Organisation (AHCDO), has developed the Gene Therapy Roadmap to provide a Clinical Implementation Plan that sets out AHCDO’s position on the preferred approach to implementation of gene therapy for haemophilia in Australia, with a focus on patient needs that is informed by clinical experience.
If you have any questions or feedback, please direct your comments to info@ahcdo.org.au
-
AHCDO and National Blood Authority; Version 1; 2016
Guidelines currently under review - update due July 2024.
The Australian Haemophilia Centre Directors' Organisation (AHCDO), in collaboration with the NBA, has developed the guidelines in order to provide multidisciplinary guidance on the management of patients with haemophilia in the Australian setting.
The guidelines are based on the World Federation of Hemophilia's Guidelines for the management of hemophilia (2nd edition), but have been adapted in order to maximise the opportunity of standardising haemophilia care in Australia.
If you have any questions or feedback, please direct your comments to info@ahcdo.org.au
Fact Sheets for Health Professionals
-
AHCDO and Haemophilia Foundation Australia; 2017
Outlines key points and includes information on who should be considered for testing, accessibility, co-infection, clinical management and bleeding disorder-related complications.
This is a collaborative publication from Australian Haemophilia Centre Directors’ Organisation (AHCDO) and Haemophilia Foundation Australia.